These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 37209974)
1. Hair concentrations of anti-malarials in returned travellers-the HAIR study: Proof of principle analysis. Steiner R; Kaulich A; Müller D; Schlagenhauf P Travel Med Infect Dis; 2023; 54():102590. PubMed ID: 37209974 [TBL] [Abstract][Full Text] [Related]
2. Mefloquine for preventing malaria during travel to endemic areas. Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100 [TBL] [Abstract][Full Text] [Related]
3. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers. Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997 [TBL] [Abstract][Full Text] [Related]
4. Malaria chemoprophylaxis regimens: a descriptive drug utilization study. Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa. Lachish T; Bar-Meir M; Eisenberg N; Schwartz E J Travel Med; 2016 Jun; 23(6):. PubMed ID: 27625401 [TBL] [Abstract][Full Text] [Related]
6. Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa. Carme B; Peguet C; Nevez G Trop Med Int Health; 1997 Oct; 2(10):953-6. PubMed ID: 9357484 [TBL] [Abstract][Full Text] [Related]
7. Knowledge, attitudes, and practices regarding antimalarial chemoprophylaxis in U.S. Peace Corps Volunteers--Africa, 2013. Landman KZ; Tan KR; Arguin PM; MMWR Morb Mortal Wkly Rep; 2014 Jun; 63(23):516-7. PubMed ID: 24918487 [TBL] [Abstract][Full Text] [Related]
11. Long term health outcomes among Returned Peace Corps Volunteers after malaria prophylaxis, 1995-2014. Tan KR; Henderson SJ; Williamson J; Ferguson RW; Wilkinson TM; Jung P; Arguin PM Travel Med Infect Dis; 2017; 17():50-55. PubMed ID: 28487213 [TBL] [Abstract][Full Text] [Related]
12. Questionnaire-based analysis of atovaquone-proguanil compared with mefloquine in the chemoprophylaxis of malaria in non-immune Japanese travelers. Kato T; Okuda J; Ide D; Amano K; Takei Y; Yamaguchi Y J Infect Chemother; 2013 Feb; 19(1):20-3. PubMed ID: 22740189 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark. Kofoed K; Petersen E J Travel Med; 2003; 10(3):150-4. PubMed ID: 12757688 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. Looareesuwan S; Wilairatana P; Chalermarut K; Rattanapong Y; Canfield CJ; Hutchinson DB Am J Trop Med Hyg; 1999 Apr; 60(4):526-32. PubMed ID: 10348224 [TBL] [Abstract][Full Text] [Related]
16. Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study. Schlagenhauf P; Tschopp A; Johnson R; Nothdurft HD; Beck B; Schwartz E; Herold M; Krebs B; Veit O; Allwinn R; Steffen R BMJ; 2003 Nov; 327(7423):1078. PubMed ID: 14604928 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: retrospective observational data. Zuckerman JN; Batty AJ; Jones ME Travel Med Infect Dis; 2009 Nov; 7(6):329-36. PubMed ID: 19945009 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan. Hitani A; Nakamura T; Ohtomo H; Nawa Y; Kimura M J Infect Chemother; 2006 Oct; 12(5):277-82. PubMed ID: 17109092 [TBL] [Abstract][Full Text] [Related]
19. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. McKeage K; Scott L Drugs; 2003; 63(6):597-623. PubMed ID: 12656656 [TBL] [Abstract][Full Text] [Related]
20. Current status and replies to frequently posed questions on atovaquone plus proguanil (Malarone) for the prevention of malaria. Kain KC BioDrugs; 2003; 17 Suppl 1():23-8. PubMed ID: 12785875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]